{
  "docId": "019de076-b0fc-7764-be49-9cb0f9de8ba9",
  "docSlug": "ed8052d583ef5c8745075e02dbad124b",
  "documentTitle": "MAIA Biotechnology | Investor Presentation Deck | 31 slides",
  "authorId": "maia-biotechnology",
  "authorName": "MAIA Biotechnology",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2024-01-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 22,
  "pageCount": 31,
  "prevPage": 21,
  "nextPage": 23,
  "slideType": "roadmap",
  "function": "plan_implementation",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": "The slide outlines a clinical trial process flow involving SCLC and NSCLC patient baskets, immune activation, and subsequent combination therapies leading to a Phase 3 expansion.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de076-b0fc-7764-be49-9cb0f9de8ba9/22",
  "deckHref": "/decks/019de076-b0fc-7764-be49-9cb0f9de8ba9",
  "deckJsonHref": "/decks/019de076-b0fc-7764-be49-9cb0f9de8ba9.json",
  "deckAnchorHref": "/decks/019de076-b0fc-7764-be49-9cb0f9de8ba9#slide-22",
  "components": [
    {
      "bbox": {
        "h": 0.55,
        "w": 0.96,
        "x": 0.02,
        "y": 0.335
      },
      "kind": "diagram",
      "text": "Process flow from Baskets (SCLC/NSCLC) through THIO administration and Immune Activation to combination therapies and Phase 3 expansion.",
      "attrs": null,
      "subkind": "process",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a3cb3612-d966-4432-8e7f-8f28f6e09755",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.35,
        "x": 0.02,
        "y": 0.95
      },
      "kind": "source-note",
      "text": "1 Dose to be selected from THIO-101 study results",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c6f43045-f0da-4258-8781-092ee839a500",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.96,
        "x": 0.02,
        "y": 0.14
      },
      "kind": "subtitle",
      "text": "A Multicenter, Open-label, Phase 2 Trial Evaluating the Safety and Efficacy of THIO Administered in Sequence with Anti-PD-1 or Anti-PD-L1",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e4a0be0a-aab0-4376-a3d1-ceb1e3911bc7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.45,
        "x": 0.02,
        "y": 0.03
      },
      "kind": "title",
      "text": "THIO-103 TRIAL (PLANNED)",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4d2aec62-b3e5-4eb3-b99e-4ce79eb40a2a",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Process flow",
      "slug": "process-flow",
      "agent": null,
      "layer": "slide",
      "matchId": "57ce8e49-c212-4f3f-93b6-689ac9c52267",
      "evidence": "diagram/process: Process flow from Baskets (SCLC/NSCLC) through THIO administration and Immune Activation to combination therapies and Phase 3 expansion.",
      "confidence": 0.8
    }
  ],
  "frameworks": [
    {
      "name": "process",
      "slug": null,
      "matchId": "9f1bde5f-60dc-4436-b8dd-31a1726967e8",
      "evidence": "The slide uses a left-to-right flow diagram to illustrate the clinical trial progression.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}